GE Healthcare Forges Five-Year Precision Medicine Partnership With Vanderbilt
GE Healthcare is making a bid to become the leader in precision medicine by collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care.
You may also be interested in...
The Dutch company received the US FDA's breakthrough device designation in 2018 for the surgical patch.
Johnson & Johnson previously agreed to acquire TachoSil but terminated the transaction due to regulatory hurdles.
Emmanuel Ligner, president and CEO of Cytiva, talks to In Vivo about how the company will dramatically increase its manufacturing capabilities over the next five years, at a price tag of $500m.